Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study

Clinical trial NCT04850235 · UNKNOWN

Trial details

NCT number: NCT04850235
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Nasopharyngeal Cancer

Start date: 2021-04-15
Primary completion: 2022-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.